EyePoint Pharmaceuticals, Inc. Underwriting Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated October 29, 2024, by and between EyePoint Pharmaceuticals, Inc. and J.P. Morgan Securities LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NY
2024
Underwriting Agreement, dated December 4, 2023, by and between EyePoint Pharmaceuticals, Inc. and J.P. Morgan Securities LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Underwriting Agreement, dated November 16, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Underwriting Agreement, dated February 1, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Underwriting Agreement, dated February 21, 2020, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NY
2020
Underwriting Agreement, dated March 28, 2019, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
PSIVIDA CORP. 4,000,000Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2016
PSIVIDA CORP. 3,494,550 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
2013